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Abstract
Background: Hepatitis C virus (HCV) infection and schistosomiasis are major public health
problems in the Nile Delta of Egypt. To control schistosomiasis, mass treatment campaigns using
tartar emetic injections were conducted in the 1960s through 1980s. Evidence suggests that
inadequately sterilized needles used in these campaigns contributed to the transmission of HCV in
the region. To corroborate this evidence, this study evaluates whether HCV infections clustered
within houses in which household members had received parenteral treatment for schistosomiasis.
Methods: A serosurvey was conducted in a village in the Nile Delta and residents were questioned
about prior treatment for schistosomiasis. Sera were evaluated for the presence of antibodies to
HCV. The GEE2 approach was used to test for clustering of HCV infections, where correlation of
HCV infections within household members who had been treated for schistosomiasis was the
parameter of interest.
Results: A history of parenteral treatment for schistosomiasis was observed to cluster within
households, OR for clustering: 2.44 (95% CI: 1.47–4.06). Overall, HCV seropositivity was 40%
(321/796) and was observed to cluster within households that had members who had received
parenteral treatment for schistosomiasis, OR for clustering: 1.76 (95% CI: 1.05–2.95). No such
evidence for clustering was found in the remaining households.
Conclusion: Clustering of HCV infections and receipt of parenteral treatment for schistosomiasis
within the same households provides further evidence of an association between the
schistosomiasis treatment campaigns and the high HCV seroprevalence rates currently observed
in the Nile delta of Egypt.
Background
Infection with the hepatitis C virus (HCV) occurs primari-
ly through percutaneous exposure to contaminated blood
or blood products. Unlike most other viral hepatitis infec-
tions that tend to be acute, hepatitis C infections are often
chronic and persist for decades [1–3]. The long-term se-
quelae of chronic HCV infections include increased risks
of liver cirrhosis and hepatocellular carcinoma [4,5].
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[6–8]. Blood bank and community-based surveys con-
ducted in Egypt have reported sero-prevalence rates of
HCV to be as high as 40% in some parts of the country [9–
12]. These rates are substantially higher in the Nile Delta
region compared with the rest of the country [13]. Schis-
tosomiasis is a parasitic infection transmitted to humans
from snails that harbor the parasite. Most rural and peri-
urban areas located in the Nile Delta are in close proxim-
ity to the distributaries of the Nile River or irrigation ca-
nals drawn from the Nile. These slow flowing waters are
infested with snails that serve as the vector for the schisto-
somal parasite. Schistosomiasis infections, in addition to
HCV are hyperendemic in the Nile Delta region [14].
In the 1960s, 1970s and early 1980s, mass campaigns
were conducted to treat schistosomiasis infections in
these areas, during which individuals older than 5 years of
age were treated with tartar emetic injections [15]. Sero-
surveys conducted in the 1990's in Egypt have reported
positive associations between HCV infections and a histo-
ry of schistosomiasis or a history of having received injec-
tions for the treatment of schistosomiasis [9,12,13,16].
Based on this evidence, the studies suggest that inade-
quately sterilized needles and syringes used during the
campaign were probable causes for transmission of HCV
in the region.
Since all the studies were conducted as cross-sectional sur-
veys, it is not possible to know whether the HCV infec-
tions were pre-existing at the time of the treatment
campaigns or whether they were incident infections as a
consequence of the campaigns. The studies have also re-
ported low prevalence rates in the younger age groups and
high prevalence rates for the older ages suggesting that in-
dividuals infected between the 1960's to the early 80's are
now older and more likely to be sero-positive compared
to those born after the campaigns. A limitation of most of
the published studies is the implicit assumption in their
analyses that all the individuals in the survey are inde-
pendent of each other and that infection rates are uni-
formly distributed both within and across all households
in the community. If the suggested nosocomial mecha-
nism of transmission were true, the assumption that infec-
tion rates are uniformly distributed would not be valid,
because HCV infections will tend to cluster within house-
holds that participated in the campaign compared to
households that did not. The uniform distribution as-
sumption is further complicated by the existence of sub-
groups of high risk and low risk individuals within each
house based on their date of birth. If a household partici-
pated in the campaign and has an infected member, there
is a greater likelihood that another member who resided
in the same house at the time of the campaign will be in-
fected, but a low likelihood that an individual born with-
in the same house after the campaign period will be
infected.
We postulate that an entire household was more likely to
have participated in the campaign if at least one member
of the household had a history of schistosomiasis and re-
ceived treatment by injections, compared to houses in
which no member reported a past history and parenteral
treatment for schistosomiasis. Based on this premise, we
would expect clustering of HCV infection in households
in which one or more members reported having received
parenteral treatment for schistosomiasis, if the underlying
reason for the spread of HCV infection was in fact attrib-
utable to the treatment campaign.
Using the HCV infection status of individuals participat-
ing in a community based sero-survey conducted in the
Nile delta of rural Egypt, we tested the following hypoth-
eses to assess if the schistosomiasis treatment campaigns
were associated with transmission of HCV:
i) Participation by village residents in the schistosomiasis
treatment campaigns were likely to cluster within houses,
with members of a house more likely to participate in the
campaign if at least one member participated.
ii) Clustering of HCV infections within houses is more
likely among houses that participated in the treatment
campaigns compared to those that did not.
Methods
Site
The study was conducted in Kalama, a semi-urban area in
Qalyub District of the Qualyabia Governorate. The village
is located on the south-east edge of the Nile River delta,
approximately 19 km north of Heliopolis, Cairo, Egypt.
Irrigated farmlands and canals surround the village, a fea-
ture typical of the Nile delta. The village has a population
of approximately 17 000 residents living in about 2400
houses. Agriculture is the primary occupation. Residents
live in small single story homes either as single nuclear
families or extended families with multiple related nucle-
ar families residing within the same house. The median
household size was 7 persons at the time of the study.
Population and sero-survey
Details of the study have been described elsewhere [16].
Briefly, after conducting a census in December 1994, the
village was divided into 12 geographic sectors. Every 15th
house was then systematically sampled for participation
in a sero-survey. Of a total of 172 sampled houses, 168
(98%) household heads agreed to participate. Between
January and June 1995, after obtaining written informed
consent, we conducted a sero-survey and administered a
questionnaire to the study participants, soliciting medicalPage 2 of 7
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schistosomiasis was obtained by interview in which par-
ticipants were asked whether they had ever received a di-
agnosis of schistosomiasis. Regardless of their histories,
all participants were further queried about past treatment
for schistosomiasis and whether the treatment was with
oral drugs, injections or both. Approximately 7 ml of
blood was then obtained via a venipuncture from each
participant. Persons under 10 years of age were excluded
from the sero-survey because earlier work in Kalama dem-
onstrated HCV infection to be rare in this age group [12].
Baseline socio-demographic information was collected at
the time of the census. Household socio-economic status
was classified as high, medium or low according to a lo-
cally developed scale. Details of the laboratory methods
used to detect anti-HCV antibodies have been described
elsewhere [16]. Briefly, serum from the blood samples
was screened for anti-HCV antibodies by EIA (Abbot Lab-
oratories). All EIA-reactive sera were evaluated with either
the second or third generation recombinant immunoblot
assays (Chiron Corporation) as confirmatory tests. Posi-
tive results by either of the immunoblot assays were con-
sidered to be HCV positive (positive for anti-HCV
antibodies).
Statistical methods
For baseline comparisons of the HCV positive and nega-
tive individuals, we used the chi-square test (or Fisher's
Exact test when there was sparse data) for categorical var-
iables. For dimensional variables, the t-test was used to
compare the two groups when the data was normally dis-
tributed, and the Mann-Whitney-U test, when assump-
tions of normality were not met.
To test for intra- and inter-class clustering of HCV infec-
tions, we used a modified formulation of the Generalized
Estimating Equations (GEE). The original formulation of
GEE also referred to as GEE1 [17] is used in the analysis of
correlated data in which clustering is treated as a nuisance
factor that needs to be taken into account at the analysis
stage. This approach uses a working correlation matrix to
model the correlation between the repeated or related ob-
servations for an individual or a cluster while simultane-
ously adjusting for covariates in a generalized linear
model. With the new formulation, also referred to as
GEE2 or Alternating Logistic Regression (ALR), clustering
can be treated as a parameter of interest on which we can
perform hypothesis testing [18–20]. Instead of specifying
a correlation matrix, an OR is computed for each cluster
in this approach to detect clustering among related obser-
vations. Since the outcome of our study is binary (HCV
positive or negative), we describe the approach for binary
outcomes.
For a family of size n, if Yj is the HCV status (0 = negative,
1 = positive) of the jth individual, we define
log [Pr(Yj = 1)/Pr(Yj = 0)] = β0 + β1x1j+ β2x2j + ...... + +
βmxmj  (1)
where the x's are m covariates for the jth individual. For
most analyses, the x's are variables that describe the base-
line characteristics or are confounding variables. These
variables could be specific to the jth individual (such as
age and gender) or could be common for the entire family
(e.g. race or socio-economic status of the family). The β's
are the regression parameters to be estimated. We next de-
fine the odds ratio (OR) between the jth and kth members
of the family as
The odds ratio is a commonly used measure of association
for categorical variables and assumes the values between
zero and infinity. An odds ratio equal to one suggests the
lack of an association between individuals. In equation
(2), an OR = 1 for each of the NC2 (number of ways in
which we can select 2 out of N) pairs of members within
a house indicates the absence of clustering of disease with-
in the family. On the other hand, an odds ratio greater
than one will indicate clustering of disease within the
families. It should be noted that the OR defined in (2) is
not the same OR that one conventionally uses to measure
the association between exposure and disease in case-con-
trol or observational studies. The OR in (2) describes the
odds of disease or no disease for another member in the
same cluster, given that a member is affected or unaffect-
ed. We henceforth refer to this OR as 'OR for clustering'.
Such ORs are commonly used to describe familial aggre-
gation of disease in genetic studies [21]. The OR can be
modeled for subclasses or sub-clusters within the main
cluster as
log ORjk = γz  (3)
Where z indicates the class membership of the (j, k) pair
within the house. For example, if we consider adults with-
in a house to be members of class 'a' and children to be
members of class 'c', then log(ORjk) = γaa, γcc, or γac de-
pending on whether the (j, k) pair are adults, children, or
an adult-child pair. From equation (3) we thus obtain two
intra-class ORs namely eγaa and eγcc for adults and chil-
dren respectively and one inter-class OR namely eγac be-
tween adults and children. A significant γaa or γcc is
suggestive of clustering within adults or within children,
whereas a significant γac is indicative of the existence of a
OR
Y Y Y Y
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j k j k
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there is a single class and the equation models a constant
log odds across all the clusters. Estimates for β's and γ's are
obtained by simultaneous estimation of the parameters
from equations (1) and (3), thereby adjusting the ORs for
covariates introduced in (1). Further details on the formu-
lation, estimation methods, features of the model, and
properties of the estimators have been published else-
where [18–20].
To model sub-groups of high and low risk groups within
houses, we chose an age cutoff of 15 years based on an ex-
amination of the age-specific prevalence within our study
and based on reports stating that parenteral treatment of
schistosomiasis was stopped between 1982 and 1986,
with the introduction of praziquintal, an oral drug used to
treat the disease [22]. Further, children under 5 years of
age were not eligible for receiving injections during the
campaigns. Since children born in 1981 would have been
14 years of age at the time of our 1995 HCV study, it can
be safely assumed that they were not present at the time of
the schistosomiasis campaigns. This age cutoff has also
been used in other studies [13].
We conducted our analysis using the ALR implementation
of GEE in SAS V8.02 (SAS Institute Inc., Cary, NC). Since
we assume that the parenteral treatment for schistosomia-
sis in the campaigns for the entire house occurred around
the same time, to model the correlation between the
members of the house, ordering of individuals within the
house (cluster) is not relevant. Hence, to model the OR
for clustering of schistosmiasis treatment in the house, an
exchangeable log odds ratio was assumed. With an ex-
changeable log odds ratio, a constant OR for clustering is
assumed for all houses. To estimate the degree of cluster-
ing of HCV infections, a history of parenteral treatment of
schistosomiasis in the house was considered to be a block-
ing factor. Separate log odds ratios were estimated for each
block with the assumption that the log odds ratios are
constant within each block.
Results
The study sample contained 910 age eligible individuals
residing in 168 houses. Of these, 810 (88%) agreed to par-
ticipate in the study and provided blood samples. The
number of participants within these houses ranged from
1 to 20 members with a median (inter-quartile range) of
4 (2 – 6) members. Anti-HCV antibodies were evaluated
for 796 (98%) of the blood samples collected. A total of
321 (40%) subjects were sero-reactive to HCV. Individu-
als positive for HCV were significantly older than those
who were negative (p < .001). Other variables measured
at baseline were comparable for the two groups. Although
not statistically significant, HCV seropositive individuals
were more frequently males and of low socio-economic
status (table 1). Age specific HCV positive prevalence rates
increase around 15 years of age suggesting the possibility
of a cohort effect (table 2). The sero-prevalence of anti-
HCV antibodies was 11% (95%CI: 6% – 16%) for chil-
dren under 15 years of age compared to 47% (95%CI:
43% – 51%) for those 15 years or older (p < .0001).
Among the 746 individuals who reported no history of
schistosomiasis or no parenteral treatment for diagnosed
schistosomiasis, the prevalence of HCV was 38% com-
pared to 68% for the 50 individuals who reported receiv-
ing the treatment (p < .0001). Examination of the degree
of clustering of HCV infections among houses with mem-
bers that received parenteral treatment indicated that
there was a significant degree of clustering of HCV infec-
tions in such houses. After adjusting for individual level
effects of age and gender, and household characteristics
such as socio-economic status and risk group based on el-
igibility for participation in the schistosomiasis treatment
campaigns, all of which were significant confounding var-
iables, the OR for clustering of HCV infections was 1.76
(95% CI: 1.05 – 2.95; p < .05) (table 3). In contrast, the
OR for clustering of HCV infections among houses in
which no member reported a history of parenteral treat-
ment for a past schistosomiasis infection was 1.37 (95%
CI: 0.92 – 2.05; p = 0.12). If we inappropriately used lo-
gistic regression and treated all participants to be inde-
pendent of each other, the odds of HCV infection among
members reporting previous parenteral schistosomiasis
treatment compared to those who did not, after adjusting
for the same confounding variables, was 1.55 (95% CI:
0.81 – 2.98; p = 0.19).
Fifty adults reported receiving injections for the treatment
of schistosomiasis. Houses in which an adult member re-
ported receiving parenteral treatment were more likely to
have other adult members with histories of parenteral
treatment for schistosomiasis. The OR for clustering of in-
dividuals receiving parenteral treatment was 2.44 (95%
CI: 1.47 – 4.06; p < 0.001), suggesting that past participa-
tion in the treatment campaigns tended to cluster within
houses.
Discussion
Our analysis reveals that there is significant amount of
clustering of HCV infections within houses of the study
village and that the infections are not distributed uniform-
ly across the village. We also demonstrate that some
households were more likely to have participated in the
schistosomiasis treatment campaigns compared to others
and that the clustering of HCV infections were more likely
among the households that participated in the treatment
campaigns. In the general population, based on the time
period during which the treatment campaigns were con-
ducted and the ensuing age distribution of the HCV infec-Page 4 of 7
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Sociodemographic Feature HCV Positive (N = 321) HCV Negative (N = 475)
Median Age (yrs) 35a (25–47) b 20 (14–30)
Female 46% 51%
Occupation of Household Headc:
Farmer 24% 17%
Manual Laborer 18% 13%
Civil Servant 19% 26%
Pensioner 8% 8%
Other 31% 36%
Type of Household Dwelling:
Village House 44% 45%
Flat 41% 37%
Other 15% 18%
Household Ownership of Dwellingd:
Owned Exclusively 86% 83%
Owned Partially 11% 11%
Rented 3% 6%
Household Luxury Itemse:
Electric Oven 64% 65%
Color Television 27% 33%




Primary Source of Drinking Water in Householde:
Municipal 68% 66%
Water Truck 32% 34%
Primary Defecation Site in Householde:
Western Toilet 3% 3%





a P < 0.001 (2-tailed) b Interquartile range. c Information available for 318 HCV positive and 469 negative individuals. d Information available for 310 
HCV positive and 459 negative individuals. e Information available for 318 HCV positive and 464 negative individuals. f Socioeconomic scale (SES); 
complete information available for 310 HCV positive and 459 HCV negative individuals
Table 2: Age-specific HCV seroprevalence rates, Kalama, Egypt 1995
Age in years Total Tested HCV Positive % Positive (95% CI)a
10–14 153 17 11% (6% – 16%)
15–24 222 63 28% (22% – 34%)
25–34 132 58 44% (36% – 52%)
35–44 116 70 60% (51% – 69%)
45–54 86 63 73% (64% – 83%)
55 + 87 50 57% (47% – 68%)
Total 796 321 40% (37% – 44%)
a % positive for HCV (95% Confidence Interval)Page 5 of 7
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temporal and possible causal relationship between these
two events has been suggested [13]. Our study adds to this
finding by studying these two events within the same pop-
ulation, thus providing further evidence that the spread of
HCV in the Nile Delta region was associated with the
schistosomiasis treatment campaign.
The observation that households were more likely to have
participated in the treatment campaign if any member
within the house participated in the campaign is corrobo-
rated by the manner in which the treatment campaigns
were conducted. Unlike mass campaigns conducted for
vaccinations, where house-to-house visits are made and
residents are immunized, the treatment campaigns were
conducted at centralized health care facilities such as hos-
pitals and clinics. In some instances, these clinics were
rolling clinics established temporarily at the villages. This
situation makes it likely that entire households rather
than random individuals would have visited the clinics
based on factors such as proximity, risk of schistosomiasis
infection to the household, and socio-economic status.
Indeed, our analysis finds that socio-economic status of a
house was strongly predictive of whether an individual
tests positive for HCV, after adjusting for the effects of
clustering.
Potential limitations of this study need to be mentioned.
Since reports of receiving injections for treatment of schis-
tosomiasis were by recall, it is possible that inaccuracies in
the recall might have biased the results of the study. Addi-
tionally, it is possible that a report by one member of the
family potentially influences the response of another fam-
ily member during the interview process. Such related re-
sponses will artificially tend to show clustering of
participation in the treatment campaigns within the hous-
es. However, since testing of sera for HCV antibodies for
the members of the family was done without knowledge
of which sera belonged to which family, and since cluster-
ing of HCV infections was observed within families inde-
pendent of the participation in the treatment campaigns,
it is unlikely that the clustering of the individuals' partici-
pation in the treatment campaigns were solely due to bi-
ased reporting since there is an a priori reason to believe
that such clustering is possible on the basis of the manner
in which the campaigns were conducted. It could be stated
that familial clustering of HCV infections may be due to
other factors or behaviors that are related to an increased
risk of schistosomiasis as well as an increased risk of HCV
infections. Alternatively, certain household behaviors
such as health care practices or tendency to visit providers
who use unsafe treatment methods, could also result in
clustering of HCV infections within the families. If this
were true and was the sole explanation for the clustering
of HCV infections within the household, we would expect
to see HCV infections in the younger children too who
were not present in the households at the time of the treat-
ment campaigns within such families. However, our pre-
vious work in this village found HCV infections among
children less than 10 years of age to be extremely rare, thus
making it less likely that unmeasured factors might be in-
fluencing this association.
Despite the use of oral drugs for the treatment of schisto-
somiasis during the past two decades, HCV antibodies
were detected in some children below 15 years of age. Ver-
tical transmission of HCV from infected mother to infant
occurs in approximately 5% of HCV infected mothers and
is reported to increase with increasing viral loads [23].
Prospective studies could help determine the relative con-
tribution of vertical and horizontal transmission of HCV
infections observed in these children.
Most previous studies that have that have found associa-
tions between histories of schistosomiasis and HCV have
either been designed as surveys or have used ecologic as-
sociations. While ecologic associations are very useful for
generating hypotheses, one should be cautious in trying
to make individual level inferences from population
based observations because of the multiple sources of bi-
ases associated with such study designs [24]. After using
the appropriate analytic methods, our results provide fur-
ther evidence for an association between the parenteral
Table 3: Evaluation of clustering of HCV seropositivity within houses that participated in the schistosomiasis treatment campaigns, 
Kalama, Egypt 1995.
Houses with treatmenta Houses with no treatmentb
Number of Houses 36 132
HCV infections 94 227
Odds Ratio for Clustering 1.76 1.37
95% Confidence Interval 1.05 – 2.95c 0.92 – 2.05d
aHouses that had one or more members reporting a diagnosis of schistosomiasis and having received treatment with injections b Houses with no 
member being treated with injections for schistosomiasis c p = 0.03 d p = 0.12Page 6 of 7
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